Quantifying the Impact of Ocrelizumab on Paramagnetic Rim Lesions in Multiple Sclerosis

ABSTRACT Paramagnetic rim lesions (PRLs) are a subset of chronic active multiple sclerosis (MS) lesions marked by iron‐laden microglia and macrophages. Ocrelizumab, a monoclonal antibody targeting CD20+ B cells, suppresses acute MS activity, but its effect on PRLs remains unclear. In a longitudinal...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Kimberly H. Markowitz, Neha V. Safi, Iliana Pliska‐Bloch, Ulrike W. Kaunzner, Ha Luu, Mert Sisman, Yi Wang, Thanh D. Nguyen, Sandra Hurtado Rúa, Susan A. Gauthier
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Wiley 2026-07-01
Cyfres:	Annals of Clinical and Translational Neurology
Pynciau:	multiple sclerosis ocrelizumab quantitative susceptibility mapping
Mynediad Ar-lein:	https://doi.org/10.1002/acn3.70357
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!